31 results on '"Flanigan, Kevin"'
Search Results
2. Health related quality of life in young, steroid-naïve boys with Duchenne muscular dystrophy
3. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials
4. The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development
5. 204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24–26 January 2014, Naarden, The Netherlands
6. Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy
7. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial
8. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network
9. Clinical and genetic characterization of manifesting carriers of DMD mutations
10. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy
11. DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy
12. A novel form of juvenile recessive ALS maps to loci on 6p25 and 21q22
13. Spinocerebellar ataxia type 31 is associated with 'inserted' penta-nucleotide repeats containing [(TGGAA).sub.n]
14. Dystrophin as a therapeutic biomarker: Are we ignoring data from the past?
15. Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2
16. Duchenne muscular dystrophy: meeting the therapeutic challenge.
17. Update in the Mucopolysaccharidoses.
18. Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
19. Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene
20. Validity and Reliability of the Neuromuscular Gross Motor Outcome.
21. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
22. Low-level dystrophin expression attenuating the dystrophinopathy phenotype.
23. Clinicopathologic Conference: A Newborn With Hypotonia, Cleft Palate, Micrognathia, and Bilateral Club Feet.
24. Recurrent Fat Embolic Strokes in a Patient With Duchenne Muscular Dystrophy With Long Bone Fractures and a Patent Foramen Ovale.
25. A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy.
26. One Year Outcome of Boys With Duchenne Muscular Dystrophy Using the Bayley-III Scales of Infant and Toddler Development.
27. NATURAL HISTORY OF CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY AND THE EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR WITH OR WITHOUT BETA-BLOCKER
28. RNA Interference Inhibits DUX4-induced Muscle Toxicity In Vivo: Implications for a Targeted FSHD Therapy.
29. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy
30. Cerebral proton magnetic resonance spectroscopy of a patient with giant axonal neuropathy
31. An unusual pathologic feature associated with dermatomyositis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.